Czech scientists in the fight against coronavirus

11. 02. 2020

Czech scientists participated in the development of a new test confirming the presence of coronavirus 2019-nCoV in the body. The company TATAA Biocenter (Göteborg, Sweden) in cooperation with the laboratory of prof. M. Kubista from the Institute of Biotechnology of the Czech Academy of Sciences and Saint James Hospital Malta) has developed a new diagnostic kit. The Red Cross has expressed interest in its use in China.

The first patient samples are being tested at Saint James Hospital, Malta.

Coronavirus 2019-nCoV belongs to the family of Coronaviridae, which causes respiratory diseases in animals and humans. The viruses in this family bring about common problems such as colds, coughs, breathing difficulties, and fevers. But they are also the cause of the deadly Severe Acute Respiratory Syndrome (SARS) and MERS (Middle East Respiratory Syndrome).

Three months have passed since the first confirmed occurrence of the new type of coronavirus 2019nCoV in Wuhan, China, and it is still spreading. According to the World Health Organization, more then 20 thousand cases and four hundred deaths have been confirmed worldwide.

Prepared by: Kateřina Sedláčková, Institute of Biotechnology CAS
Foto: iStock

The Czech Academy of Sciences (the CAS)

The mission of the CAS

The primary mission of the CAS is to conduct research in a broad spectrum of natural, technical and social sciences as well as humanities. This research aims to advance progress of scientific knowledge at the international level, considering, however, the specific needs of the Czech society and the national culture.

President of the CAS

Prof. Eva Zažímalová has started her second term of office in May 2021. She is a respected scientist, and a Professor of Plant Anatomy and Physiology.

She is also a part of GCSA of the EU.